The purified component of HEMATOPORPHYRIN DERIVATIVE, it consists of a mixture of oligomeric porphyrins. It is used in photodynamic therapy (HEMATOPORPHYRIN PHOTORADIATION); to treat malignant lesions with visible light and experimentally as an antiviral agent. It is the first drug to be approved in the use of PHOTODYNAMIC THERAPY in the United States.
Dihematoporphyrin Ether has been studied across 12 research domains including 🔬 Oncology, ✨ Skin & Hair, 😴 Sleep, 🫁 Respiratory, 🧠 Focus & Attention. The primary research focus is 🔬 Oncology with 62% of studies addressing this area.
This evidence profile for Dihematoporphyrin Ether is generated deterministically from 102 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.
Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.